Edrecolomab in the adjuvant treatment of colorectal carcinoma

Lancet. 2003 Jan 4;361(9351):83; author reply 83. doi: 10.1016/S0140-6736(03)12146-0.
No abstract available

Publication types

  • Letter
  • Comment

MeSH terms

  • Antibodies, Monoclonal / metabolism
  • Antibodies, Monoclonal / therapeutic use*
  • Antibodies, Monoclonal, Murine-Derived
  • Cell Adhesion Molecules / metabolism
  • Chemotherapy, Adjuvant
  • Colorectal Neoplasms / drug therapy*
  • Colorectal Neoplasms / metabolism
  • Humans
  • Immunohistochemistry
  • Treatment Failure

Substances

  • Antibodies, Monoclonal
  • Antibodies, Monoclonal, Murine-Derived
  • Cell Adhesion Molecules
  • Edrecolomab